Optimizing the sequencing of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC)
収録刊行物
-
- Lung Cancer
-
Lung Cancer 137 113-122, 2019-11
Elsevier BV